342 filings
8-K
ARIA
ARIAD Pharmaceuticals Inc
16 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
6 Feb 17
ARIAD Announces Submission of Marketing Authorization Application for Brigatinib to the European Medicines Agency
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
10 Jan 17
Entry into a Material Definitive Agreement
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
8 Dec 16
Other Events
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
7 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
xfb5bbzt
30 Nov 16
Other Events
12:00am
8-K
plmaa1v
18 Nov 16
ARIAD Announces Data Presentations at the World Conference on Lung Cancer
12:00am
8-K
z8c9fx
7 Nov 16
ARIAD Reports Third Quarter 2016 Financial Results
12:00am
8-K
iv2sqi 99280p
31 Oct 16
ARIAD Announces U.S. Food and Drug Administration Acceptance of NDA Filing for Brigatinib
12:00am
8-K
0l3h3 xlece
29 Sep 16
ARIAD Announces Regulatory Approval for Iclusig® (ponatinib) in Japan
12:00am
8-K
yuhsyoqtqps
30 Aug 16
ARIAD Completes Rolling Submission of New Drug Application for Brigatinib to the U.S. Food and Drug Administration
12:00am
8-K
caz9 11a0mef
28 Jul 16
ARIAD Reports Second Quarter and First Half 2016 Financial Results
12:00am
8-K
ma8lo5n9qo6pl6
22 Jul 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
7esx44l0c36ehv
7 Jun 16
Other Events
12:00am
8-K
r23aga
2 Jun 16
Entry into a Material Definitive Agreement
12:00am
8-K
dzvzf0d kee
26 May 16
Ariad Announces Appointment of Jennifer L. Herron
12:00am
8-K
see1nv
20 May 16
Departure of Directors or Certain Officers
12:00am
8-K
quhv0e qfi75emixm
19 May 16
ARIAD Announces Data Presentations at the 2016 ASCO Annual Meeting
12:00am
8-K
xpvdhmc
10 May 16
ARIAD Reports First Quarter 2016 Financial Results and Progress on Strategic Review
12:00am
8-K
yv5 kgd5xs5s853e
9 May 16
Incyte and Ariad Announce Agreement for Incyte to Acquire
12:00am